|
Market Closed -
Nasdaq
20:00:00 26/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 10.00 USD | -0.40% |
|
+16.01% | +29.53% |
| 10-15 | Verastem's G12D Drug Shows Promise in Pancreatic Cancer, Shares Undervalued, RBC Says | MT |
| 10-15 | Mizuho Raises Price Target on Verastem to $14 From $13, Keeps Outperform Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VSTM | Delayed | |
CBOE
| VSTM | Real-time | |
|
Tradegate
| 2VSA | Real-time | |
|
Deutsche Boerse AG
| 2VSA | Delayed | |
|
Börse Stuttgart
| 2VSA | Delayed | |
|
Boerse Muenchen
| 2VSA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 10.06 | 10.06 | 10.64 |
| Spread/Res. | -0.60% | -0.60% | -6.02% |
| Spread/Supp. | +19.47% | +75.75% | +169.54% |
| Support | 8.37 | 5.69 | 3.71 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VSTM Stock
- Charts Verastem, Inc.
Select your edition
All financial news and data tailored to specific country editions
